[CONFIDENTIAL TREATMENT REQUESTED BY IKANG GUOBIN HEALTHCARE GROUP, INC. SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS American Depositary Shares iKang Guobin Healthcare Group, Inc. Representing Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Guobin Healthcare Group, Inc. We are offering ADSs. Each ADS represents Class A common shares, par] [Equity Transfer Contract “Contract” This Equity Transfer Contract (the The Transferor: He Boquan ID No.: 440620196011075452 Address: No. 18, Lane 1, Yinglong Street, Xiaolan Town, Zhongshan City, Guangdong Province The Transferee: Shanghai iKang Guobin Holding Co., Ltd. Address: Room 3182, No. 2123, Pudong Avenue, Shanghai WHEREAS: “Guobin Healthcare Center” 1. Shanghai Guobin Healthcare Center Co., Ltd. ( 2. The Transferor] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Address: th 701, 7 Party B: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. Party Parties Party A and Party B are hereinafter individually referred to as a “ WHEREAS, 1. Party A is a wholly-owned subsidiary registered in] [Equity Pledge Agreement “Agreement This Equity Pledge Agreement (the Party A: Pledgee th st Address: 701, 7 Party B: ID Number: 320102198102151619 Party C: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. the Party the Parties For the purpose of this Agreement, the Pledgee, Pledgors and Party C are individually referred to as “ Whereas:] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: Party B: Party C: Party Parties In this Agreement, Party A, Party B and Party C are referred to as a “ WHEREAS: Party B, Hu Haiqing holds 80% of the equity interest in Party C on behalf of Party A; Party A regularly provides Party C] [Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Jiandatong Health Technology (Beijing) Co., Ltd., hereby irrevocably authorize ShanghaiMed iKang, Inc. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: ShanghaiMed iKang, Inc. is hereby authorized to act] [Statement and Acknowledgment I, as the shareholder of the 20% equity interest in Jiandatong Health Technology (Beijing) Co., Ltd. (hereinafter referred to as “Company”), hereby state and acknowledge that, in the event that Mr. Hu Haiqing transfers, in whole or in part, the 80% equity interest in the Company held by him to any third party, I agree to such] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated February 14, 2014 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc. its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012]